No Egos Allowed: Jones Day, Winner of the Litigation Department of the Year

[caption id="attachment_5417" align="alignnone" width="557"]

(l-r) John Majoras, Sharyl Reisman, Lee Armstrong, Anthony Insogna, Stephanie Parker[/caption] By fall 2016, Jones Day’s Intellectual property group leader, Anthony Insogna, knew that the patent case he was handling for Merck & Co. subsidiary Idenix would be going in front of a jury. Idenix had brought patent infringement claims against Gilead Sciences over Gilead’s hepatitis C drug Sovaldi in federal court in Delaware. With trial all but certain and just two months away, he called up one of his partners in Atlanta, Stephanie Parker, and asked her to be trial counsel. Parker, the co-head of Jones Day’s business and tort litigation practice—affectionately known as BATL in the firm—had never tried an intellectual property case. But as R.J. Reynolds Co.’s lead counsel in the “Engle progeny” tobacco litigation in Florida, she had plenty of experience presenting complex arguments to juries. She said yes. It turned out to be a good move. In December 2016, after nine days of trial and less than two hours of deliberation, the jury awarded Merck a stunning $2.54 billion in damages, the largest patent infringement award in U.S. history. This isn’t (just) a story about a star litigator jumping into a case at the last minute to deliver a spectacular result, though. It’s about a firm assembling the best team across practice group lines to handle a client problem. Of the four lawyers at the counsel table for Idenix in the Delaware courtroom, Parker says, two of them she’d never met before her first pretrial conference. It didn’t matter. “Anthony and his team did a great job of working up the case,” Parker says. She brought in some of her own top product liability litigators, including partners Steven Geise and Bradley Harrison. “Everyone stepped up,” says BATL co-chairman John Majoras. “Very senior lawyers were involved in background work.” Merck general counsel Michael Holston says he has rarely seen a firm that worked together so well to get the job done. “Stephanie Parker and the team delivered one of the best trial performances I’ve ever seen,” he says. “From trial preparation through posttrial, the work was exceptional across the board.” Jones Day, which had not represented Merck before the Idenix case, wound up with a spot on Merck’s preferred provider list as a result. Jones Day litigators take particular pride in how well they collaborate, calling it a focus on client service. Many in the firm cite Jones Day’s “black box” compensation system and lack of origination credits, which reduce the incentive to hoard work and client relationships. “All of our clients are considered firm clients, and no particular partner ‘owns’ a client,” says Insogna. What’s clear is that the ability to harness the right talent from across the firm’s 1,100-litigator ranks helped Jones Day litigators deliver a big victory in the Idenix case and many others. In the contest period, August 2015 through July 2017, Jones Day won in forums that ranged from the U.S. Supreme Court to the trenches of state court, recovered billions for companies it represented, and turned back billions more in claims against other clients.